Epigenetic crosstalk between uric acid and vascular health: a role for extracellular vesicles Authors: Concetta Schiano, Claudio Napoli Published: 2025 Dear Editor, We read with great interest the study by Beik-Khormizi et al. [1], which reported differential expression of DNA methyltransferases (DNMT) 3A, DNMT3B, Histone Deacetylase (HDAC) 3, and HDAC7 in peripheral blood mononuclear cells (PBMCs) from healthy young males stratified both by subclinical atherosclerosis and hyperuricemia. The upregulation of DNMT3A and concomitant downregulation of DNMT3B and HDAC3/7 reported in individuals with elevated uric acid (UA) levels or undergoing premature coronary angiography (CPCA) is particularly interesting. These findings indicate that early epigenetic remodeling can occur independently of traditional cardiovascular risk factors. Extracellular vesicles (EVs) may play a central role in mediating the UA-associated epigenetic alterations described [2]. We have demonstrated that EVs isolated from the plasma of patients with acute coronary syndrome can induce de novo DNA methylation in endothelial cells through the transfer of DNMTs or their upstream regulators. Therefore, similar mechanisms may be active in individuals with hyperuricemia or early atherosclerosis. Given the pro-inflammatory and oxidative properties of UA, it is plausible that UA triggers the release of EVs enriched in epigenetic modulators, such as DNMTs or microRNAs (miRNAs) targeting HDACs, which can epigenetically reprogram the recipient’s immune or vascular cells (Fig. 1). Future analyses may involve the following experimental steps: isolation and characterization of EVs derived from plasma or serum from individuals with hyperuricemia and CPCA; and molecular profiling of the EV cargo, including DNMTs, HDACs, long noncoding RNAs, and miRNAs with known epigenetic targets. Functional tests are needed to evaluate the impact of these EVs on recipient PBMCs or endothelial cells, focusing on gene-specific DNA methylation, histone modification patterns, and downstream gene expression. Proposed mechanism of hyperuricemia-induced epigenetic remodeling in early atherosclerosis via extracellular vesicles (EVs). Elevated uric acid (UA) levels in the bloodstream can induce oxidative and inflammatory stress by triggering the release of EVs from immune cells and vascular cells. These EVs carry DNA methyltransferases, such as DNMT3A and DNMT3B; histone deacetylases, such as HDAC3 and HDAC7; and regulatory miRNAs or long noncoding RNAs. Once taken up by peripheral blood mononuclear cells (PBMCs) or endothelial cells, EVs can modulate gene-specific DNA methylation and histone modification leading to epigenetic reprogramming contributing to premature atherosclerosis independent of traditional cardiovascular risk factors These studies would clarify whether UA-induced epigenetic changes are mediated by EV-dependent paracrine signaling rather than cell-autonomous mechanisms. If confirmed, circulating EVs could emerge as early circulating biomarkers of cardiovascular risk identifying targets for preventive strategies. Sincerely, Concetta Schiano. Author contributions The authors declare no competing interests. Funding This work was supported by grant EPI-GERAS project PNRR PE00000015 funded by Ministry of Research. Data availability No datasets were generated or analysed during the current study. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.